FDA Releases Data on AMR in Salmonella, Campylobacter
The U.S. Food and Drug Administration (FDA) recently released the National Antimicrobial Resistance Monitoring System (NARMS) Integrated Summary for 2019. NARMS is a national public health system that tests bacteria from human and animal samples to monitor select pathogens’ antimicrobial resistance (AMR) to drugs used in human and veterinary medicine. NARMS is conducted in cooperation with the U.S. Centers for Disease Control and Prevention (CDC) and the U.S. Department of Agriculture’s Food Safety and Inspection Service (USDA FSIS). FDA, CDC, and FSIS are responsible for testing bacteria from raw retail meats, from human patients, and from animals at slaughter, respectively.
NARMS collects bacterial isolates from 15 distinct sources, but the summary prioritizes certain pathogens and antimicrobial drugs. Salmonella and Campylobacter are highlighted, along with drug classes that are considered most important to human medicine. FDA provides a comprehensive, interactive tool to review all the data from 2019 and previous years, called “NARMS Now: Integrated Data.”